Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.

× No keyword cloud information.

8 in total

1. Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes.

Authors: A LLerena; R Berecz; A de la Rubia; P Fernández-Salguero; P Dorado
Journal: Ther Drug Monit Date: 2001-12 Impact factor: 3.681

2. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital.

Authors: Adrián LLerena; Alfredo de la Rubia; Eva M Peñas-Lledó; Francisco J Diaz; Jose de Leon
Journal: Schizophr Res Date: 2002-12-01 Impact factor: 4.939

3. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.

Authors: K W Bock; D Schrenk; A Forster; E U Griese; K Mörike; D Brockmeier; M Eichelbaum
Journal: Pharmacogenetics Date: 1994-08

4. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.

Authors: Roland Berecz; Alfredo de la Rubia; Pedro Dorado; Pedro Fernández-Salguero; Marja-Liisa Dahl; Adrián LLerena
Journal: Eur J Clin Pharmacol Date: 2003-03-28 Impact factor: 2.953

5. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.

Authors: Jacek Wójcikowski; Patrick Maurel; Władysława A Daniel
Journal: Drug Metab Dispos Date: 2005-11-04 Impact factor: 3.922

No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.

1. Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes.

2. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital.

3. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.

4. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.

5. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.

6. Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients.

7. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.

8. Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity.